Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Psychological distress in young adults with well-controlled psoriasis
Authors:ID Merzel Šabović, Eva Klara (Author)
ID Kraner Šumenjak, Tadeja (Author)
ID Janić, Miodrag (Author)
Files:.pdf PDF - Presentation file, download (782,26 KB)
MD5: 512B9146D695CA738B8DA5D6938B28E9
 
URL URL - Source URL, visit https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1753103/full
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Introduction: Psychological distress is common in psoriasis, but its prevalence and possible biological correlates in young adults with well-controlled disease remain unclear. In this study, we aimed to assess the presence of anxiety and depressive symptoms in young, well-treated psoriasis patients, who were primarily expected to have no or minimal psychological distress, and to explore potential associations with inflammatory and metabolic markers. Methods: In a cross-sectional cohort of 80 psoriasis patients (women/male: 45/35; mean age 38.7 ± 4.2 years) psychological symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS), with HADS-A and HADS-D subscales evaluating anxiety and depression symptoms. Exploratory associations with inflammatory cytokines and metabolic indices were examined using regression analyses and random forest machine-learning models. Results: Anxiety symptoms were identified only in 5 patients (women/male: 4/1; 6%), and depressive symptoms in 10 patients (women/male: 6/4; 12%). Affected individuals had clinically significant anxiety (HADS-A: 12/21) and borderline depressive symptoms (HADS-D: 10/21). No significant associations between HADS scores and inflammatory or metabolic markers were found. Exploratory random forest models tentatively identified IL-6, IL-23, FIB-4, HOMA-IR, and waist circumference as the strongest contributors to variance in depressive symptoms, while no clear contributors emerged for anxiety. Discussion: Anxiety and depressive symptoms can occur in well-treated young psoriasis patients. Although prevalence is low, their impact may be substantial. These findings indicate the potential importance of targeted psychological screening in this population. Associations with inflammatory and metabolic markers should be considered hypothesis-generating and warrant validation in larger, independent cohorts.
Keywords:psoriasis, HADS, depression, anxiety, treatment, young patients
Publication status:Published
Publication version:Version of Record
Year of publishing:2026
Number of pages:str. 1-8
Numbering:Vol. 16, [article no.] 1753103
PID:20.500.12556/DiRROS-25261 New window
UDC:616.5
ISSN on article:1664-0640
DOI:10.3389/fpsyt.2025.1753103 New window
COBISS.SI-ID:264461059 New window
Note:Nasl. z nasl. zaslona; Opis vira z dnhe 13. 1. 2026;
Publication date in DiRROS:14.01.2026
Views:134
Downloads:70
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in psychiatry
Shortened title:Front. psychiatry
Publisher:Frontiers Research Foundation
ISSN:1664-0640
COBISS.SI-ID:54153314 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0308-2019
Name:Ateroskleroza in tromboza

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:psoriaza, HADS, depresija, anksioznost, zdravljenje, mladi bolniki


Back